Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network
  • USA - Français
  • USA - Deutsch
  • USA - español
  • USA - English

Affidea Logo

News provided by

Affidea BV

Nov 04, 2024, 07:14 ET

Share this article

Share toX

Share this article

Share toX

Affidea introduces the Roczen platform from Reset Health for the management of obesity and type 2 diabetes, offering personalised care, GLP-1 medications, and improved health outcomes for patients

THE HAGUE, Netherlands, Nov. 4, 2024 /PRNewswire/ -- Affidea, the leading pan-European provider of community-based polyclinics, advanced diagnostics and specialist services, is excited to announce a strategic long-term collaboration with Reset Health for the implementation of Roczen, a doctor-led, digital care model designed to treat and manage obesity and type 2 diabetes.

This new solution will be rolled out across Affidea markets in the coming period, offering patients access to a clinically proven, data-driven care pathway that combines advanced analytics with evidence-based interventions to improve health outcomes in managing obesity and its related chronic conditions.

Designed as a fully digital, doctor-led service, the platform addresses obesity and type 2 diabetes by combining sustainable lifestyle changes with new innovative medical interventions.

Key features include:

  • Comprehensive pathway to support patients
  • Continuous tracking of vital health metrics to provide timely interventions.
  • Personalised treatment plans based on real-time patient data and health needs.
  • Direct communication between patients and healthcare providers for better management and ongoing support.
  • Support offered on sustainable behaviour changes, including dietary modifications, physical activity, and mental health.
  • Access to GLP-1 medications for qualifying patients, supporting comprehensive chronic disease management.

Affidea's collaboration with Reset Health and the introduction of the Roczen platform marks a significant step in expanding Affidea's clinical services to meet the growing demand for effective weight and diabetes management solutions. This partnership aligns with Affidea's mission to deliver innovative, patient-focused care pathways, ensuring patients have access to the latest therapeutic options, including GLP-1 medications. By integrating digital therapeutics with professional healthcare support, Affidea's centres will offer personalised, accessible, and affordable care, helping patients manage obesity and type 2 diabetes more effectively while reducing the risk of long-term complications.

Dr Charles Niehaus, Executive Director for Affidea Group, commented: "At Affidea, we are dedicated to providing the highest quality of care for our patients, tailored for their individual needs. The Roczen platform we are now implementing for a comprehensive pathway allows us to offer a clinically validated approach to weight management and diabetes care that directly addresses two of the most pressing health issues of our time. By offering personalised, evidence-based interventions, we are empowering our patients to take control of their health and improve their quality of life."

Dr David Wong, Chairman at Reset Health, said: "We are excited to partner with Affidea and together be at the forefront of delivering high-quality, clinically-proven weight management and diabetes care across Europe. By providing access to Roczen, our doctor-led care model, we will support people living with obesity and type 2 diabetes to have individualised care that is tailored to their needs. By improving patient experience and engagement, we seek to deliver better outcomes."

Key Facts on Obesity and its Impact, according to WHO:

  • Nearly 60% of adults in Europe are overweight, and 23% are classified as obese. One in three school-aged children is also classified as obese.
  • 1.2 million deaths annually in the European region are attributable to overweight and obesity.
  • By 2030, projections from the World Health Organization (WHO) suggest that obesity rates in Europe could rise by 10-15%, with as many as 30% of adults becoming obese.
  • Obesity is strongly linked to type 2 diabetes, with 80-90% of individuals with type 2 diabetes being overweight or obese.
  • Around 70% of individuals with obstructive sleep apnea are obese.
  • Obesity increases the risk of osteoarthritis in the knee by four times.
  • There is a 33% increased risk of Alzheimer's disease and a 64% increased risk of any dementia for obese patients.
  • There is a strong correlation between obesity and mental health issues, including depression, anxiety, and eating disorders.

About Affidea

Affidea (www.affidea.com) is a leading pan-European provider of community-based polyclinics, advanced diagnostics and specialist services. Founded in 1991, the company operates 380 centres across 15 countries, providing high-quality medical services to nearly 14 million patients every year. Due to its track record for patient safety, the company has become the most awarded diagnostic imaging provider in Europe by the European Society of Radiology, as over 90% of its centres are recognised on the Eurosafe Wall of Stars by the European Society of Radiology. Affidea is majority-owned by Groupe Bruxelles Lambert (GBL), a leading investment holding company, focused on long-term value-creation with a stable and supportive family shareholder base.

About Reset Health

Reset Health (www.resethealth.clinic) is a digital health company delivering scalable clinical solutions and is a leader in personalised lifestyle interventions. Reset's digital platform and care model, Roczen (www.roczen.com), is used in conjunction with new anti-obesity medications, GLP-1s and GIPs, to enhance health outcomes of patients with obesity and associated co-morbidities. Reset Health is regulated by the Care Quality Commission and recommended by the National Institute of Clinical Excellence (NICE). Reset Health is the provider of obesity and Type 2 Diabetes care across the UK and Malaysia where it delivers its programmes and platform to over 500,000 people, working with governments, employers, insurers, private providers and health systems.

Logo: https://mma.prnewswire.com/media/942742/4502210/Affidea_Group_Logo.jpg

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Affidea Group se asocia con Reset Health para el control de la diabetes y la pérdida de peso

Affidea Group se asocia con Reset Health para el control de la diabetes y la pérdida de peso

Affidea, el proveedor paneuropeo líder de policlínicas comunitarias, diagnósticos avanzados y servicios especializados, se complace en anunciar una...

Affidea Group arbeitet mit Reset Health zusammen, um eine klinisch orientierte digitale Lösung zur Gewichtsabnahme und zum Diabetesmanagement in ihrem Netzwerk einzuführen

Affidea Group arbeitet mit Reset Health zusammen, um eine klinisch orientierte digitale Lösung zur Gewichtsabnahme und zum Diabetesmanagement in ihrem Netzwerk einzuführen

Affidea, der führende paneuropäische Anbieter von gemeindebasierten Polikliniken, fortschrittlicher Diagnostik und spezialisierten Dienstleistungen,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

Fitness/Wellness

Fitness/Wellness

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.